1. Efficacy and safety of re-administration of epidermal growth factor receptor-tyrosine kinase
   inhibitor (EGFR-TKI) after EGFR-TKI-induced interstitial lung disease (CS-Lung-005)
   Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, Takashi Ninomiya, Toshiyuki Kozuki, Nobuhisa Ishikawa,
   Kazuya Nishii, Hiroyasu Shoda, Kakuhiro Yamaguchi, Keita Kawakado, Yuko Toyoda, Masaaki Inoue,
   Nobuyuki Miyatake, Naoki Watanabe, Takuya Inoue, Hitoshi Mizoguchi,Yuta Komori,
   Kazuki Kojima, Norimitsu Kadowaki
   Lung 202: 63-72, 2024.
2. Comparison of impressions of COVID-19 vaccinations stratified by the number of vaccinations among Japanese healthcare professional university students
   Akihiro Yokoyama , Hiromi Suzuki , Hiroaki Kataoka, Yoshiro Mori , Yuji Watanabe, Nobuyuki Miyatake
   Cureus 16: e55861, 2024. NEW

△このページの先頭へ